Compliance | May 28th, 2020 Land O’ Lakes Faces 401(k) Excessive Fee Suit The lawsuit also questions a fee arrangement between the plan’s recordkeeper and an advice provider.
Compliance | May 27th, 2020 JPMorgan Chase to Pay $9 Million to Settle 401(k) Self-Dealing Suit The suit claimed conflicts of interest damaged net-of-fee performance.
Compliance | May 26th, 2020 Washington University 403(b) Challenge Revived by 8th Circuit Parts of the lower court’s ruling against the plaintiffs’ claims have been rejected and remanded by the appeals court.
Compliance | May 26th, 2020 Banner Health ERISA Litigation Reaches Mixed Ruling A judge found that plaintiffs failed to offer evidence that removing certain funds caused economic loss, but the ruling sided...
Compliance | May 26th, 2020 Cornell University 403(b) Plan Suit Could Face ‘Considerable’ Delay Though claims in the case were pared down last fall, the plaintiffs have requested a jury trial, so a federal...
Compliance | May 19th, 2020 Share Class Issues Cited in ManTech ERISA Lawsuit The new complaint closely resembles others that have been filed by the Capozzi Adler P.C. law firm.
Ask the Experts | May 19th, 2020 Does e-Disclosure Rule Allow for Postcard Notification of Links? Experts from Groom Law Group and Cammack Retirement Group answer questions concerning retirement plan administration and regulations.
Compliance | May 14th, 2020 Judge Permits BBVA ERISA Money Market Lawsuit to Proceed The lawsuit accuses BBVA of mismanaging a $100 million money market fund ‘that was the investment equivalent of stuffing cash...
Compliance | May 13th, 2020 New ERISA Excessive Fee Complaint Targets Aegis Fiduciaries The plan in question in smaller than many that have been subject to excessive fee litigation, underscoring the trend that...
Compliance | May 11th, 2020 Second ERISA Lawsuit Targets ADP Multiple Employer Plan The second suit, filed on behalf of participants rather than plan sponsors, largely mirrors the first in its allegations of...
Compliance | May 6th, 2020 Lawsuit Alleges Excessive Fees in Multiple Employer Plan Though the plan’s recordkeeper is not named as a defendant, the lawsuit says fiduciaries of the ADP TotalSource Retirement Savings...
Compliance | May 5th, 2020 Automotive Manufacturer New Target of ERISA Excessive Fee Suit The complaint also argues that the structure of Magna International of America’s plan “is rife with potential conflicts of interest.”
Compliance | May 5th, 2020 Court Dismisses Johnson & Johnson Stock Drop Suit Johnson & Johnson successfully argued that the plaintiffs have not met the pleading standards established by Fifth-Third v. Dudenhoeffer, however,...
Compliance | May 4th, 2020 Use of Incorrect Compensation Definition Alleged in Lawsuit Against Host International The plaintiff in the case says Host’s tip policy interferes with his and others’ ability to defer income under the...
Compliance | May 1st, 2020 University of Miami Faces Lawsuit Over 403(b) Plan Fees The plaintiffs say they seek similar remedies as those in a settlement that was court-approved in a case against Duke...
Compliance | May 1st, 2020 DOL, Wilmington Trust Reach Agreement Over ESOP Overpricing The agreement requires Wilmington Trust to pay $80 million to 21 employee stock ownership plans (ESOPs) for which it served...
Compliance | April 30th, 2020 Lawsuit Challenging Pension Transfer in Corporate Restructuring Dismissed A federal district court judge noted that the 9th U.S. Circuit Court of Appeals has held that the “decision to...
Compliance | April 30th, 2020 Family Owners Charged with ESOP Buyback Violations in New ERISA Lawsuit The lawsuit is directly tied into another in which Wilmington Trust agreed in January to a settlement valued at $5...
Compliance | April 29th, 2020 ERISA Lawsuit Against Trader Joe’s Dismissed A federal judge said the plaintiffs' guess of recordkeeping fees paid had no factual basis and failed to claim a...
Compliance | April 29th, 2020 Barrick Gold Faces Lawsuit About 401(k) Investment Selections The lawsuit is nearly identical to one filed by the same law firm against a pharmaceutical company.